TY  - JOUR
AU  - Izquierdo, Guillermo
AU  - Damas, Fátima
AU  - Páramo, Maria Dolores
AU  - Ruiz-Peña, Juan Luis
AU  - Navarro, Guillermo
PY  - 2017
DO  - 10.1371/journal.pone.0176174
UR  - http://hdl.handle.net/10668/11145
T2  - PloS one
AB  - Fingolimod approval was based mainly on two clinical trials, FREEDOMS and TRANSFORMS, which demonstrated the efficacy and safety of fingolimod in patients with multiple sclerosis (MS). We present an observational study that validates these trials...
LA  - en
KW  - Adult
KW  - Disabled Persons
KW  - Female
KW  - Fingolimod Hydrochloride
KW  - Humans
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - Recurrence
KW  - Retrospective Studies
KW  - Safety
TI  - The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study.
TY  - research article
VL  - 12
ER  -